Amended in Senate May 5, 2015

Amended in Senate April 22, 2015

Amended in Senate March 23, 2015

Senate BillNo. 253


Introduced by Senator Monning

(Principal coauthor: Assembly Member Chiu)

(begin deleteCoauthor: Senatorend deletebegin insertCoauthors: Senatorsend insert Beallbegin insert and Lenoend insert)

(Coauthor: Assembly Member Gatto)

February 18, 2015


An act to amend Sectionbegin insert 4064.5 of the Business and Professions Code, and to amend Sectionend insert 369.5 of the Welfare and Institutions Code, relating to juveniles.

LEGISLATIVE COUNSEL’S DIGEST

SB 253, as amended, Monning. Dependent children: psychotropic medication.

Existing law establishes the jurisdiction of the juvenile court, which may adjudge children to be dependents of the court under certain circumstances, including when the child suffered or there is a substantial risk that the child will suffer serious physical harm, or a parent fails to provide the child with adequate food, clothing, shelter, or medical treatment. Existing law authorizes only a juvenile court judicial officer to make orders regarding the administration of psychotropic medications for a dependent child who has been removed from the physical custody of his or her parent. Existing law requires the court authorization for the administration of psychotropic medication to a child be based on a request from a physician, indicating the reasons for the request, a description of the child’s diagnosis and behavior, the expected results of the medication, and a description of any side effects of the medication.

This bill would require that an order authorizing the administration of psychotropic medications to a dependent child be granted only upon the demonstration of clear and convincing evidence that administration of the medication is in the best interest of the child and the court determines that specified requirements have been met, including a requirement that the prescribing physician confirms that he or she has conducted a comprehensive evaluation of the child, as specified. The bill would prohibit the court from authorizing the administration of psychotropic medications to a child under other specified circumstances, unless a 2nd independent medical opinion is obtained from a child psychiatrist or a psychopharmacologist. The bill would prohibit the court from authorizing the administration of a psychotropic medication unless the court is provided documentation that appropriate screenings and tests for the child have been completed no more than 30 days prior to submission of the request to the court. The bill would impose additional requirements on the court to implement these provisions and to conduct review hearings, as specified.begin insert The bill would authorize psychotropic medication to be administered in an emergency without court authorization. The bill would require court authorization to be sought as soon as practical, but in no case more than 2 court days after emergency administration of the psychotropic medication.end insert The bill would require the Judicial Council to adopt rules to implement these provisions.

Vote: majority. Appropriation: no. Fiscal committee: yes. State-mandated local program: no.

The people of the State of California do enact as follows:

P2    1begin insert

begin insertSECTION 1.end insert  

end insert

begin insertSection 4064.5 of the end insertbegin insertBusiness and Professions
2Code
end insert
begin insert is amended to read:end insert

3

4064.5.  

(a) A pharmacist may dispense not more than a 90-day
4supply of a dangerous drug other than a controlled substance
5pursuant to a valid prescription that specifies an initial quantity of
6less than a 90-day supply followed by periodic refills of that
7amount if all of the following requirements are satisfied:

8(1) The patient has completed an initial 30-day supply of the
9dangerous drug.

P3    1(2) The total quantity of dosage units dispensed does not exceed
2the total quantity of dosage units authorized by the prescriber on
3the prescription, including refills.

4(3) The prescriber has not specified on the prescription that
5dispensing the prescription in an initial amount followed by
6periodic refills is medically necessary.

7(4) The pharmacist is exercising his or her professional
8judgment.

9(b) For purposes of this section, if the prescription continues
10the same medication as previously dispensed in a 90-day supply,
11the initial 30-day supply under paragraph (1) of subdivision (a) is
12not required.

13(c) A pharmacist dispensing an increased supply of a dangerous
14drug pursuant to this section shall notify the prescriber of the
15increase in the quantity of dosage units dispensed.

16(d) In no case shall a pharmacist dispense a greater supply of a
17dangerous drug pursuant to this section if the prescriber personally
18indicates, either orally or in his or her own handwriting, “No
19change to quantity,” or words of similar meaning. Nothing in this
20subdivision shall prohibit a prescriber from checking a box on a
21prescription marked “No change to quantity,” provided that the
22prescriber personally initials the box or checkmark. To indicate
23that an increased supply shall not be dispensed pursuant to this
24section for an electronic data transmission prescription as defined
25in subdivision (c) of Section 4040, a prescriber may indicate “No
26change to quantity,” or words of similar meaning, in the
27prescription as transmitted by electronic data, or may check a box
28marked on the prescription “No change to quantity.” In either
29instance, it shall not be required that the prohibition on an increased
30supply be manually initialed by the prescriber.

31(e) This sectionbegin delete shallend deletebegin insert doesend insert not apply to psychotropic medication
32or psychotropic drugs as described inbegin delete subdivision (d) ofend delete Section
33369.5 of the Welfare and Institutions Code.

34(f) Nothing in this section shall be construed to require a health
35care service plan, health insurer, workers’ compensation insurance
36plan, pharmacy benefits manager, or any other person or entity,
37including, but not limited to, a state program or state employer, to
38provide coverage for a dangerous drug in a manner inconsistent
39with a beneficiary’s plan benefit.

P4    1

begin deleteSECTION 1.end delete
2begin insertSEC. 2.end insert  

Section 369.5 of the Welfare and Institutions Code is
3amended to read:

4

369.5.  

(a) If a child is adjudged a dependent child of the court
5under Section 300 and the child has been removed from the
6physical custody of the parent under Section 361, only a juvenile
7court judicial officer shall have authority to make orders regarding
8the administration of psychotropic medications for that child. The
9juvenile court may issue a specific order delegating this authority
10to a parent upon making findings on the record that the parent
11poses no danger to the child and has the capacity to authorize
12psychotropic medications. Court authorization for the
13administration of psychotropic medication shall be based on a
14request from a physician, indicating the reasons for the request, a
15description of the child’s diagnosis and behavior, the expected
16 results of the medication, and a description of any side effects of
17the medication. On or before July 1, 2016, the Judicial Council
18shall adopt rules of court and develop appropriate forms for
19implementation of this section. Whenever the court authorizes the
20administration of a psychotropic medication, it shall ensure that
21the administration of the psychotropic medication is only one part
22of a comprehensive treatment plan for the child that shall include
23and specify the psychosocial services the child will receive in
24addition to any authorized medication.

25(b) (1) An order authorizing the administration of psychotropic
26medications pursuant to this section shall only be granted on clear
27and convincing evidence that administration of the medication is
28in the best interest of the child based on a determination that the
29 anticipated benefits of the psychotropic medication outweigh the
30short- and long-term risks associated with the medications.begin insert An
31order authorizing the administration of psychotropic medication
32 pursuant to this section shall not be granted if the court determines
33that the medication is being used as punishment, for the
34convenience of staff, as a substitute for other less invasive
35treatments, or in quantities or dosages that interfere with the
36child’s treatment program.end insert

37(2) An order authorizing the administration of psychotropic
38medications pursuant to this section shall only be granted if the
39court determines all of the following:

begin delete

P5    1(A) The medication is not being used as punishment, for the
2convenience of staff, as a substitute for other, less invasive
3treatments, or in quantities or dosages that interfere with the child’s
4treatment program.

end delete
begin delete

5(B)

end delete

6begin insert(A)end insert The court is provided documentation confirming the child’s
7caregiver has been informed, and the child has been informed in
8an age and developmentally appropriate manner, about the
9recommended medications, the anticipated benefits, the nature,
10degree, duration, and probability of side effects and significant
11risks commonly known by the medical profession, and of
12psychosocial treatments to be considered concurrently with or as
13an alternative to the medication.

14(i) The documentation shall state that the child and the child’s
15caregiver have been asked whether either have concerns regarding
16the medication, and if so, shall describe the nature of those
17concerns. The documentation shall confirm that the child has been
18informed of the right to request a hearing pursuant to subdivision
19(g).

20(ii) The documentation shall include the written informed
21consent of a child who is 14 years of age or older, after being
22advised pursuant to this subparagraph.

begin delete

23(C)

end delete

24begin insert(B)end insert The prescribing physician submitting the request for
25psychotropic medication confirms that he or she conducted a
26comprehensive examination of the child in compliance with Section
272242 of the Business and Professions Code and consistent with
28the Psychiatric Evaluation and Diagnosis provisions included in
29the Guidelines for the Use of Psychotropic Medication with
30Children and Youth in Foster Care issued by the state, which takes
31into account all of the following:

32(i) The child’s trauma history.

33(ii) The child’s medical records, including medication history.

34(iii) Multiple sources of information, including, but not limited
35to, the child, the child’s parents, relatives, teacher, caregiver or
36caregivers, past prescribers of psychotropic medication, or other
37health care providers.

begin delete

38(D)

end delete

39begin insert(C)end insert The prescribing physician shall also confirm all of the
40following:

P6    1(i) There are no less invasive and effective treatment options
2available to meet the needs of the child.

3(ii) The dosage or dosage range requested is appropriate for the
4child.

5(iii) The short- and long-term risks associated with the use of
6psychotropic medications by the child does not outweigh the
7reported benefits to the child.

8(iv) All appropriate lab screenings, measurements, or tests for
9the child have been completed in accordance with accepted medical
10guidelines.

begin delete

11(E)

end delete

12begin insert(D)end insert A plan is in place for regular monitoring of the child’s
13medication and psychosocial treatment plan, the effectiveness of
14the medication and psychosocial treatment, and any potential side
15effects of the medication, by the physician in consultation with
16the caregiver, mental health care provider, and others who have
17contact with the child, as appropriate.

begin delete

15 18(2)

end delete

19begin insert(3)end insert The person or entity submitting the request for authorization
20of the administration of psychotropic medication shall bear the
21burden of proof established in this section.

22(c) A court shall not issue an order authorizing the administration
23of psychotropic medications for a child unless a second
24independent medical opinion is obtained from a child psychiatrist
25or a psychopharmacologist if one or more of the following
26circumstances exist:

27(1) The request is for any class of psychotropic medication for
28a child who is five years of age or younger.

29(2) The request would result in the child being administered
30three or more psychotropic medications concurrently.

31(3) The request is for the concurrent administration of any two
32drugs from the same class unless the request is for medication
33tapering and replacement that is limited to no more than 30 days.

34(4) The request is for a dosage that exceeds the amount
35recommended for children.

36(5) The request is for the administration of a psychotropic
37medication that is subject to a federal Food and Drug
38Administration black box warning requirement or is for the
39administration of an antipsychotropoic medication for a use that
P7    1is not approved by the federal Food and Drug Administration for
2children or adolescents.

3(d) The court shall not authorize the administration of the
4psychotropic medication unless the court is provided
5documentation that all of the appropriate lab screenings,
6measurements, or tests for the child have been completed in
7accordance with accepted medical guidelines no more than 30 days
8prior to submission of the request to the court.

9(e) (1) No later than 60 days after the authorization of a new
10psychotropic medication is granted or at the next review hearing
11scheduled for the child pursuant to Section 366, 366.21, 366.22,
12or 366.31, if scheduled no earlier than 45 days after the
13authorization of a new psychotropic medication, the court shall
14conduct a review hearing to determine all of the following:

15(A) Whether the child is taking the medication or medications.

16(B) Whether psychosocial services and other aspects of the
17child’s treatment plan have been provided to the child.

18(C) To what extent the symptoms for which the medication or
19medications were authorized have been alleviated.

begin insert

20(D) Whether more time is needed to evaluate the effectiveness
21of the medication or medications.

end insert
begin delete

22(D)

end delete

23begin insert(E)end insert What, if any, adverse effects the child has suffered.

begin delete

24(E)

end delete

25begin insert(F)end insert Any steps taken to address those effects.

begin delete

26(F)

end delete

27begin insert(G)end insert The date or dates of followup visits with the prescribing
28physician since the medication or medications were authorized.

begin delete

29(G)

end delete

30begin insert(H)end insert Whether the appropriate followup laboratory screenings
31have been performed and their findings.

32(2) If based upon this review, the court determines that the
33proffered benefits of the medication have not been demonstrated
34or that the risks of the medication outweigh the benefits, the court
35shall reconsider, modify, or revoke its authorization for the
36administration of medication.

37(f) (1) In counties in which the county child welfare agency
38completes the request for authorization for the administration of
39psychotropic medication, the agency is encouraged to complete
P8    1the request within three business days of receipt from the physician
2of the information necessary to fully complete the request.

3(2) Nothing in this subdivision is intended to change current
4local practice or local court rules with respect to the preparation
5and submission of requests for authorization for the administration
6of psychotropic medication.

7(g) Within seven court days from receipt by the court of a
8completed request, the juvenile court judicial officer shall either
9approve or deny in writing a request for authorization for the
10administration of psychotropic medication to the child, or shall,
11upon a request by the parent, the legal guardian, or the child’s
12attorney, or upon its own motion, set the matter for hearing.

13(h) Psychotropic medication or psychotropic drugs are those
14medications administered for the purpose of affecting the central
15nervous system to treat psychiatric disorders or illnesses. These
16medications include, but are not limited to, anxiolytic agents,
17antidepressants, mood stabilizers, antipsychotic medications,
18anti-Parkinson agents, hypnotics, medications for dementia, and
19psychostimulants.

begin insert

20(i) (1) Psychotropic medications may be administered without
21court authorization in an emergency. An emergency exists if all
22of the following conditions are met:

end insert
begin insert

23(A) A physician finds that the child requires psychotropic
24medication to treat a psychiatric disorder or illness.

end insert
begin insert

25(B) The medication is immediately necessary for the preservation
26of life or the prevention of serious bodily harm to the child or
27others. It is not necessary for the harm to take place or become
28unavoidable prior to treatment.

end insert
begin insert

29(C) It is impractical to obtain authorization from the court
30before administering the psychotropic medication to the child.

end insert
begin insert

31(2) Court authorization shall be sought as soon as practical,
32but in no case more than two court days after the emergency
33administration of psychotropic medication.

end insert
begin delete

34(i)

end delete

35begin insert(j)end insert Nothing in this section is intended to supersede local court
36rules regarding a minor’s right to participate in mental health
37decisions.

begin delete

38(j)

end delete

P9    1begin insert(k)end insert This section shall not apply to nonminor dependents, as
2defined in subdivision (v) of Section 11400.



O

    96